
MultiPlan Corporation (NYSE: MPLN) Stock Competitors & Peer Comparison
See MPLN's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MPLN and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MPLN | $23.15 | -1.53% | 375M | -0.23 | -$101.92 | N/A |
| VEEV | $195.38 | -1.01% | 31.7B | 23.46 | $8.33 | N/A |
| GEHC | $63.07 | -4.00% | 28.7B | 13.83 | $4.56 | +0.22% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $70.69 | +3.71% | 13.9B | 57.01 | $1.24 | N/A |
| BTSGU | $231.53 | +1.23% | 13.5B | 209.36 | $1.11 | N/A |
| TEM | $52.47 | -2.09% | 9.2B | -104.94 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $97.67 | +2.73% | 8.3B | 23.06 | $4.28 | N/A |
| HNGE | $87.09 | +1.29% | 6.7B | 44.66 | $1.95 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
MPLN vs VEEV Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, VEEV has a market cap of 31.7B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while VEEV trades at $195.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas VEEV's P/E ratio is 23.46. In terms of profitability, MPLN's ROE is +2.06%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, MPLN is more volatile compared to VEEV. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
MPLN vs GEHC Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, GEHC has a market cap of 28.7B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while GEHC trades at $63.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas GEHC's P/E ratio is 13.83. In terms of profitability, MPLN's ROE is +2.06%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, MPLN is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
MPLN vs GEHCV Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas GEHCV's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, MPLN is more volatile compared to GEHCV. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
MPLN vs BTSG Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, BTSG has a market cap of 13.9B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while BTSG trades at $70.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas BTSG's P/E ratio is 57.01. In terms of profitability, MPLN's ROE is +2.06%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, MPLN is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
MPLN vs BTSGU Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, BTSGU has a market cap of 13.5B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while BTSGU trades at $231.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas BTSGU's P/E ratio is 209.36. In terms of profitability, MPLN's ROE is +2.06%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, MPLN is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
MPLN vs TEM Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, TEM has a market cap of 9.2B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while TEM trades at $52.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas TEM's P/E ratio is -104.94. In terms of profitability, MPLN's ROE is +2.06%, compared to TEM's ROE of -0.70%. Regarding short-term risk, MPLN is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
MPLN vs SGFY Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas SGFY's P/E ratio is 70.91. In terms of profitability, MPLN's ROE is +2.06%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, MPLN is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
MPLN vs HQY Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, HQY has a market cap of 8.3B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while HQY trades at $97.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas HQY's P/E ratio is 23.06. In terms of profitability, MPLN's ROE is +2.06%, compared to HQY's ROE of +0.11%. Regarding short-term risk, MPLN is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
MPLN vs HNGE Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, HNGE has a market cap of 6.7B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while HNGE trades at $87.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas HNGE's P/E ratio is 44.66. In terms of profitability, MPLN's ROE is +2.06%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, MPLN is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
MPLN vs RCM Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas RCM's P/E ratio is -102.21. In terms of profitability, MPLN's ROE is +2.06%, compared to RCM's ROE of +0.00%. Regarding short-term risk, MPLN is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
MPLN vs TXG Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, TXG has a market cap of 5.6B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while TXG trades at $43.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas TXG's P/E ratio is -257.29. In terms of profitability, MPLN's ROE is +2.06%, compared to TXG's ROE of -0.03%. Regarding short-term risk, MPLN is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check TXG's competition here
Doximity, Inc. (NYSE: DOCS)
MPLN vs DOCS Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, DOCS has a market cap of 4B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while DOCS trades at $21.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas DOCS's P/E ratio is 14.07. In terms of profitability, MPLN's ROE is +2.06%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, MPLN is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
MPLN vs ONEM Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas ONEM's P/E ratio is -7.77. In terms of profitability, MPLN's ROE is +2.06%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, MPLN is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
MPLN vs PRVA Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, PRVA has a market cap of 3.4B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while PRVA trades at $26.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas PRVA's P/E ratio is 168.13. In terms of profitability, MPLN's ROE is +2.06%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, MPLN is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
MPLN vs PGNY Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while PGNY trades at $31.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas PGNY's P/E ratio is 23.31. In terms of profitability, MPLN's ROE is +2.06%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, MPLN is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
MPLN vs HTFL Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, HTFL has a market cap of 2.2B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while HTFL trades at $24.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas HTFL's P/E ratio is -12.92. In terms of profitability, MPLN's ROE is +2.06%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, MPLN is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
MPLN vs WGS Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, WGS has a market cap of 1.9B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while WGS trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas WGS's P/E ratio is 74.68. In terms of profitability, MPLN's ROE is +2.06%, compared to WGS's ROE of -0.28%. Regarding short-term risk, MPLN is more volatile compared to WGS. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check WGS's competition here
Teladoc Health, Inc. (NYSE: TDOC)
MPLN vs TDOC Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, TDOC has a market cap of 1.7B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while TDOC trades at $9.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas TDOC's P/E ratio is -10.47. In terms of profitability, MPLN's ROE is +2.06%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, MPLN is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
MPLN vs NXGN Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas NXGN's P/E ratio is -266.00. In terms of profitability, MPLN's ROE is +2.06%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, MPLN is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
MPLN vs OMDA Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while OMDA trades at $23.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas OMDA's P/E ratio is 338.57. In terms of profitability, MPLN's ROE is +2.06%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, MPLN is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
MPLN vs AGTI Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas AGTI's P/E ratio is -71.79. In terms of profitability, MPLN's ROE is +2.06%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, MPLN is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
MPLN vs GDRX Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, GDRX has a market cap of 1.1B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while GDRX trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas GDRX's P/E ratio is 9.52. In terms of profitability, MPLN's ROE is +2.06%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, MPLN is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check GDRX's competition here
Certara, Inc. (NASDAQ: CERT)
MPLN vs CERT Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while CERT trades at $6.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas CERT's P/E ratio is 17.77. In terms of profitability, MPLN's ROE is +2.06%, compared to CERT's ROE of -0.01%. Regarding short-term risk, MPLN is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check CERT's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
MPLN vs CCLDO Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas CCLDO's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, MPLN is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
MPLN vs HSTM Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, HSTM has a market cap of 845.5M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while HSTM trades at $28.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas HSTM's P/E ratio is 38.08. In terms of profitability, MPLN's ROE is +2.06%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, MPLN is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check HSTM's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
MPLN vs WGSWW Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, WGSWW has a market cap of 748M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas WGSWW's P/E ratio is -0.02. In terms of profitability, MPLN's ROE is +2.06%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, MPLN is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check WGSWW's competition here
Phreesia, Inc. (NYSE: PHR)
MPLN vs PHR Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, PHR has a market cap of 662M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while PHR trades at $10.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas PHR's P/E ratio is 38.25. In terms of profitability, MPLN's ROE is +2.06%, compared to PHR's ROE of +0.03%. Regarding short-term risk, MPLN is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check PHR's competition here
Evolent Health, Inc. (NYSE: EVH)
MPLN vs EVH Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, EVH has a market cap of 652.4M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while EVH trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas EVH's P/E ratio is 580.00. In terms of profitability, MPLN's ROE is +2.06%, compared to EVH's ROE of -0.78%. Regarding short-term risk, MPLN is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check EVH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
MPLN vs MPLN-WT Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, MPLN is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
MPLN vs ACCD Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas ACCD's P/E ratio is -3.08. In terms of profitability, MPLN's ROE is +2.06%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, MPLN is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
MPLN vs SHCR Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas SHCR's P/E ratio is -3.76. In terms of profitability, MPLN's ROE is +2.06%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, MPLN is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check SHCR's competition here
Claritev Corporation (NYSE: CTEV)
MPLN vs CTEV Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, CTEV has a market cap of 517.5M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while CTEV trades at $30.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas CTEV's P/E ratio is -2.33. In terms of profitability, MPLN's ROE is +2.06%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, MPLN is more volatile compared to CTEV. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check CTEV's competition here
NRC Health (NASDAQ: NRC)
MPLN vs NRC Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, NRC has a market cap of 490.8M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while NRC trades at $21.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas NRC's P/E ratio is 26.56. In terms of profitability, MPLN's ROE is +2.06%, compared to NRC's ROE of +0.57%. Regarding short-term risk, MPLN is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
MPLN vs SOPH Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, SOPH has a market cap of 403.5M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while SOPH trades at $5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas SOPH's P/E ratio is -11.29. In terms of profitability, MPLN's ROE is +2.06%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, MPLN is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
MPLN vs SLGCW Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, MPLN's ROE is +2.06%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, MPLN is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
MPLN vs SLGC Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas SLGC's P/E ratio is -3.04. In terms of profitability, MPLN's ROE is +2.06%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, MPLN is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check SLGC's competition here
TruBridge, Inc. (NASDAQ: TBRG)
MPLN vs TBRG Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas TBRG's P/E ratio is 9.37. In terms of profitability, MPLN's ROE is +2.06%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, MPLN is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check TBRG's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
MPLN vs SLP Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, SLP has a market cap of 368.7M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while SLP trades at $18.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas SLP's P/E ratio is 20.72. In terms of profitability, MPLN's ROE is +2.06%, compared to SLP's ROE of +0.06%. Regarding short-term risk, MPLN is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
MPLN vs TRHC Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas TRHC's P/E ratio is -4.27. In terms of profitability, MPLN's ROE is +2.06%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, MPLN is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
MPLN vs SMFR Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas SMFR's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, MPLN is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
MPLN vs SPOK Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, SPOK has a market cap of 222.2M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while SPOK trades at $10.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas SPOK's P/E ratio is 17.73. In terms of profitability, MPLN's ROE is +2.06%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, MPLN is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check SPOK's competition here
So-Young International Inc. (NASDAQ: SY)
MPLN vs SY Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, SY has a market cap of 220.4M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while SY trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas SY's P/E ratio is -5.09. In terms of profitability, MPLN's ROE is +2.06%, compared to SY's ROE of -0.16%. Regarding short-term risk, MPLN is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check SY's competition here
American Well Corporation (NYSE: AMWL)
MPLN vs AMWL Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, AMWL has a market cap of 220.3M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while AMWL trades at $13.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas AMWL's P/E ratio is -2.54. In terms of profitability, MPLN's ROE is +2.06%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, MPLN is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
MPLN vs HCAT Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, HCAT has a market cap of 166.3M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while HCAT trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas HCAT's P/E ratio is 11.25. In terms of profitability, MPLN's ROE is +2.06%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, MPLN is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
MPLN vs CPSI Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas CPSI's P/E ratio is -183.80. In terms of profitability, MPLN's ROE is +2.06%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, MPLN is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
MPLN vs OPRX Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, OPRX has a market cap of 125.5M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while OPRX trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas OPRX's P/E ratio is 6.14. In terms of profitability, MPLN's ROE is +2.06%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, MPLN is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
MPLN vs AUGX Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas AUGX's P/E ratio is -4.99. In terms of profitability, MPLN's ROE is +2.06%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, MPLN is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
MPLN vs CCLD Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, CCLD has a market cap of 98.6M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while CCLD trades at $2.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas CCLD's P/E ratio is 8.59. In terms of profitability, MPLN's ROE is +2.06%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, MPLN is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
MPLN vs DH Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, DH has a market cap of 80.1M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while DH trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas DH's P/E ratio is 2.92. In terms of profitability, MPLN's ROE is +2.06%, compared to DH's ROE of -0.67%. Regarding short-term risk, MPLN is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
MPLN vs FORA Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas FORA's P/E ratio is -24.11. In terms of profitability, MPLN's ROE is +2.06%, compared to FORA's ROE of -0.17%. Regarding short-term risk, MPLN is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
MPLN vs CCLDP Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas CCLDP's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, MPLN is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
MPLN vs ONMD Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, ONMD has a market cap of 38.7M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while ONMD trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas ONMD's P/E ratio is -4.53. In terms of profitability, MPLN's ROE is +2.06%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, MPLN is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
MPLN vs SNCE Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas SNCE's P/E ratio is -0.27. In terms of profitability, MPLN's ROE is +2.06%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, MPLN is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
MPLN vs AKLI Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas AKLI's P/E ratio is -0.71. In terms of profitability, MPLN's ROE is +2.06%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, MPLN is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
MPLN vs SHLT Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas SHLT's P/E ratio is -3.87. In terms of profitability, MPLN's ROE is +2.06%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, MPLN is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
MPLN vs SHCRW Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, MPLN's ROE is +2.06%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, MPLN is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
MPLN vs ONMDW Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, ONMDW has a market cap of 27.7M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas ONMDW's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, MPLN is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
MPLN vs STRM Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas STRM's P/E ratio is -2.40. In terms of profitability, MPLN's ROE is +2.06%, compared to STRM's ROE of -0.32%. Regarding short-term risk, MPLN is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
MPLN vs RNLX Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas RNLX's P/E ratio is -0.33. In terms of profitability, MPLN's ROE is +2.06%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, MPLN is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
MPLN vs LIFW Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas LIFW's P/E ratio is -0.02. In terms of profitability, MPLN's ROE is +2.06%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, MPLN is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check LIFW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
MPLN vs EUDA Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, EUDA has a market cap of 21.1M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while EUDA trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas EUDA's P/E ratio is -21.32. In terms of profitability, MPLN's ROE is +2.06%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, MPLN is more volatile compared to EUDA. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check EUDA's competition here
Babylon Holdings Limited (NYSE: BBLN)
MPLN vs BBLN Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas BBLN's P/E ratio is -0.04. In terms of profitability, MPLN's ROE is +2.06%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, MPLN is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
MPLN vs BEATW Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, BEATW has a market cap of 13.4M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas BEATW's P/E ratio is -0.04. In terms of profitability, MPLN's ROE is +2.06%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, MPLN is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check BEATW's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
MPLN vs ETAO Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas ETAO's P/E ratio is -0.01. In terms of profitability, MPLN's ROE is +2.06%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, MPLN is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
MPLN vs BFRG Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, BFRG has a market cap of 7.5M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while BFRG trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas BFRG's P/E ratio is -1.20. In terms of profitability, MPLN's ROE is +2.06%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, MPLN is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check BFRG's competition here
Cue Health Inc. (NASDAQ: HLTH)
MPLN vs HLTH Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas HLTH's P/E ratio is -0.02. In terms of profitability, MPLN's ROE is +2.06%, compared to HLTH's ROE of -0.90%. Regarding short-term risk, MPLN is less volatile compared to HLTH. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check HLTH's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
MPLN vs SCNX Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, SCNX has a market cap of 6.4M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while SCNX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas SCNX's P/E ratio is -0.16. In terms of profitability, MPLN's ROE is +2.06%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, MPLN is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
MPLN vs UPH Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas UPH's P/E ratio is -0.07. In terms of profitability, MPLN's ROE is +2.06%, compared to UPH's ROE of -1.05%. Regarding short-term risk, MPLN is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
MPLN vs UPH-WT Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, MPLN is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
MPLN vs MGRX Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, MGRX has a market cap of 4.2M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while MGRX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas MGRX's P/E ratio is -0.31. In terms of profitability, MPLN's ROE is +2.06%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, MPLN is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
MPLN vs PEAR Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas PEAR's P/E ratio is -0.08. In terms of profitability, MPLN's ROE is +2.06%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, MPLN is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
MPLN vs PEARW Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas PEARW's P/E ratio is -0.00. In terms of profitability, MPLN's ROE is +2.06%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, MPLN is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
MPLN vs OTRK Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas OTRK's P/E ratio is -0.02. In terms of profitability, MPLN's ROE is +2.06%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, MPLN is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check OTRK's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
MPLN vs VSEEW Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, VSEEW has a market cap of 2.2M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while VSEEW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas VSEEW's P/E ratio is -0.06. In terms of profitability, MPLN's ROE is +2.06%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, MPLN is more volatile compared to VSEEW. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check VSEEW's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
MPLN vs HCTI Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, HCTI has a market cap of 2.1M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while HCTI trades at $1.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas HCTI's P/E ratio is -0.23. In terms of profitability, MPLN's ROE is +2.06%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, MPLN is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
MPLN vs CMAX Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas CMAX's P/E ratio is -0.00. In terms of profitability, MPLN's ROE is +2.06%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, MPLN is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
MPLN vs VSEE Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, VSEE has a market cap of 1.6M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while VSEE trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas VSEE's P/E ratio is -0.19. In terms of profitability, MPLN's ROE is +2.06%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, MPLN is more volatile compared to VSEE. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
MPLN vs ACON Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while ACON trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas ACON's P/E ratio is -0.24. In terms of profitability, MPLN's ROE is +2.06%, compared to ACON's ROE of -0.54%. Regarding short-term risk, MPLN is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
MPLN vs LIFWZ Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, MPLN is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
MPLN vs EUDAW Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, MPLN's ROE is +2.06%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, MPLN is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
MPLN vs WORX Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, WORX has a market cap of 693.4K. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while WORX trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas WORX's P/E ratio is -0.76. In terms of profitability, MPLN's ROE is +2.06%, compared to WORX's ROE of -0.65%. Regarding short-term risk, MPLN is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
MPLN vs MSPRZ Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, MPLN is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
MPLN vs KERN Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas KERN's P/E ratio is -0.01. In terms of profitability, MPLN's ROE is +2.06%, compared to KERN's ROE of -0.17%. Regarding short-term risk, MPLN is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
MPLN vs KERNW Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas KERNW's P/E ratio is -0.00. In terms of profitability, MPLN's ROE is +2.06%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, MPLN is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
MPLN vs LIFWW Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas LIFWW's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, MPLN is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
MPLN vs ZCMD Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, ZCMD has a market cap of 58K. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while ZCMD trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas ZCMD's P/E ratio is -0.06. In terms of profitability, MPLN's ROE is +2.06%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, MPLN is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
MPLN vs CMAXW Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas CMAXW's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, MPLN is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
MPLN vs ACONW Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, ACONW has a market cap of 11.7K. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas ACONW's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, MPLN is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
MPLN vs MTBCO Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas MTBCO's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, MPLN is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check MTBCO's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
MPLN vs MSPRV Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas MSPRV's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to MSPRV's ROE of N/A. Regarding short-term risk, MPLN is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
MPLN vs MTBCP Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas MTBCP's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, MPLN is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
MPLN vs MTBC Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas MTBC's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, MPLN is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
MPLN vs CHNG Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas CHNG's P/E ratio is -152.72. In terms of profitability, MPLN's ROE is +2.06%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, MPLN is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check CHNG's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
MPLN vs CHNGU Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas CHNGU's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, MPLN is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check CHNGU's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
MPLN vs CNVY Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas CNVY's P/E ratio is -71.50. In terms of profitability, MPLN's ROE is +2.06%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, MPLN is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check CNVY's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
MPLN vs NAVA Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas NAVA's P/E ratio is N/A. In terms of profitability, MPLN's ROE is +2.06%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, MPLN is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for MPLN.Check NAVA's competition here
Cerner Corporation (NASDAQ: CERN)
MPLN vs CERN Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, CERN has a market cap of 0. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas CERN's P/E ratio is 55.84. In terms of profitability, MPLN's ROE is +2.06%, compared to CERN's ROE of +0.14%. Regarding short-term risk, MPLN is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check CERN's competition here
Castlight Health, Inc. (NYSE: CSLT)
MPLN vs CSLT Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas CSLT's P/E ratio is -37.27. In terms of profitability, MPLN's ROE is +2.06%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, MPLN is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for MPLN.Check CSLT's competition here
NantHealth, Inc. (NASDAQ: NH)
MPLN vs NH Comparison July 2026
MultiPlan Corporation (NYSE: MPLN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN stands at 375M. In comparison, NH has a market cap of 0. Regarding current trading prices, MPLN is priced at $23.15 on the NYSE, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN currently has a P/E ratio of -0.23, whereas NH's P/E ratio is -0.12. In terms of profitability, MPLN's ROE is +2.06%, compared to NH's ROE of +0.35%. Regarding short-term risk, MPLN is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for MPLN.Check NH's competition here